PHARMACEUTICAL COMPOSITION FOR INHIBITION OF INTERLEUKIN-2-DEPENDENT MALIGNANT CELL PROLIFERATION, INCREASE -INTERFERON CONTENT, TREATMENT OF INTESTINE INFLAMMATORY DISEASE, POTENTIATION OF CYTOKIN PRODUCING INHIBITION AND LIMITATION OR INHIBITION OF THE DELAYED TYPE ALLERGIC REACTION

摘要

FIELD: pharmacy, bioactive substances. SUBSTANCE: pharmaceutical composition has at least one pharmaceutically acceptable carrier and active substance. Active substance is taken from the group involving interleukin-4, interleukin-10, combination of interleukin-4 and interleukin-10 and antibodies against interleukin-4 and interleukin-10 taken at effective amount. EFFECT: enhanced effectiveness of composition.